Moderna Inc (MRNA)
$147.19 10.21 (6.49%)
15:53 EST MRNA Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap -
PE Ratio -
Volume (Avg. Vol.) 7.15M
Day's Range 146.44 - 154.47
52-Week Range 19.31 - 189.26
Dividend & Yield N/A (N/A)
MRNA Stock Predictions, Articles, and Moderna Inc News
- From InvestorPlace
- From the Web
Nvidia, Moderna, Domino's Pizza and Best Buy were our top stock trades for Friday. Now, let's look at what the charts are trying to tell us.
Moderna stock investors should be glad to know that the government is ordering huge quantities of Covid-19 vaccines from just two companies.
Stocks in companies that deliver long-term success are still the secret to wealth accumulation
Robinhood bans now include trading restrictions on 50 popular Reddit stocks like SNDL, CCIV, GME, AMC and NOK. Here's what to know.
Moderna’s ability to create innovative formulae with its mRNA technology hints at a much greater upside for Moderna stock in the future.
With markets surging, there is growing skepticism about risky stocks. But there are still many interesting opportunities to consider.
The travel and hospitality industry is a sector that should thrive in 2021. In fact, travel is one of Eric Fry's four "Power Trends" in the new year.
Moderna stock is trading at 16 times forward price-to-earnings, quite an unrealistic multiple, considering the vaccine race is tightening.
Covid-19 pharma stocks like NVAX stock and BNTX stock are making headlines as Joe Biden promises to vaccinate 100 million Americans.
The wild volatility in Moderna stock before and after its vaccine approval is coming to an end but its long-term prospects are on the way up.
Pharmaceutical stocks have many benefits, particularly when their products are in demand. And in 2021, that seems likely to be the case.
There’s a lot of potential in the healthcare space thanks to new technologies, and we believe that we have found the best high-quality stocks to play the massive upside.
MRNA stock will continue to slowdown as its Covid 19 vaccine gains are priced-in and with the competiton chomping away at its market share
Moderna's vaccine for Covid-19 proves its operating system for creating new drugs works. That means more growth is ahead for MRNA stock.
As one of the leaders in the Covid-19 vaccine race, Moderna’s success boosted MRNA stock. But with real-time obstacles coming into the picture, the narrative moving forward isn’t as exciting.
Technology and biotech stocks brought in more winning picks than usual, thanks partly to the strong stock market. Here are some of my best calls.
If you’re interested in buying this dip in Moderna, it’s important to understand that you’re investing in mRNA technology more than MRNA stock.
From Market News Video
From Talk Markets
Navellier RatingsPowered by Portfolio Grader